8-K: Concentra Prices $650 Million Senior Notes Offering to Fund Separation from Select Medical

Concentra Escrow Issuer Corporation has priced a $650 million offering of senior notes due 2032 to finance its separation from Select Medical Holdings Corporation.

Summary

• Concentra Escrow Issuer Corporation, a subsidiary of Concentra Health Services, Inc., has entered into a purchase agreement for a $650 million offering of 6.875% senior notes due 2032.
• The proceeds will be held in escrow until a planned merger between the Escrow Issuer and Concentra Health Services, Inc., which is expected to occur in the third quarter of 2024.
• If the merger does not occur by September 30, 2024, the notes will be subject to a special mandatory redemption at 100% of the initial issue price plus accrued interest.
• Concentra intends to use $50 million of the net proceeds for general corporate purposes and the remainder, along with new senior secured credit facility borrowings, will be paid to Select Medical Corporation as a dividend.
• The notes are being offered in a private placement to qualified institutional buyers and non-U.S. persons.

Sentiment

Score: 7

Explanation: The document outlines a significant financing event that is part of a strategic separation. While there are risks associated with the merger not completing, the overall tone is positive, indicating a planned and structured transaction. The use of proceeds is clearly defined, and the terms of the offering are reasonable.

Positives

• The offering provides significant funding for Concentra's separation from Select Medical.
• The notes are guaranteed by Concentra and certain of its subsidiaries, enhancing their security.
• The use of proceeds includes a $50 million allocation for general corporate purposes, providing flexibility for Concentra.
• The private placement allows for a targeted offering to qualified institutional buyers.

Negatives

• The merger is not guaranteed and could be delayed or not occur at all.
• If the merger fails, the notes will be subject to a special mandatory redemption, which could impact investors.
• A significant portion of the proceeds will be used to pay a dividend to Select Medical, rather than being reinvested in Concentra's business.

Risks

• The merger is not guaranteed and could be delayed or not occur at all, triggering a mandatory redemption of the notes.
• The success of the separation of Concentra from Select Medical is subject to various conditions, including securing additional financing.
• The notes are being offered in a private placement, which may limit their liquidity.
• There is a risk that the planned senior secured credit facility may not be secured on the expected terms.

Future Outlook

The merger between Concentra Escrow Issuer Corporation and Concentra Health Services, Inc. is expected to occur in the third quarter of 2024, subject to certain conditions. The separation of Concentra from Select Medical is also contingent on securing additional financing.

Management Comments

• Select Medical and Concentra announced the pricing of the $650 million senior notes offering.
• The notes are being offered in connection with Select's plan to pursue a separation of Concentra.

Industry Context

This transaction is part of a broader trend of corporate separations and spin-offs, where companies seek to unlock value by focusing on core businesses. The healthcare industry is seeing increased activity in this area as companies look to streamline operations and improve financial performance.

Comparison to Industry Standards

• The 6.875% interest rate on the senior notes is within the typical range for similar high-yield debt offerings in the current market.
• The use of an escrow account for the proceeds is a standard practice in transactions involving mergers and acquisitions.
• The private placement structure is common for offerings targeting qualified institutional buyers.
• The mandatory redemption clause if the merger fails is a protective measure for investors, similar to other deals with uncertain closing conditions.
• Comparable companies in the healthcare services sector have also used debt financing to fund strategic initiatives, such as acquisitions or spin-offs.

Related Party Transactions

• The document mentions that a portion of the proceeds from the notes offering will be used to pay a dividend to Select Medical Corporation, which is a related party.

Stakeholder Impact

• Shareholders of Select Medical will receive a dividend from the proceeds of the notes offering.
• Investors in the senior notes will be subject to the terms of the offering, including the risk of mandatory redemption if the merger does not occur.
• Employees of Concentra will be impacted by the separation from Select Medical.
• Customers and suppliers of Concentra will be impacted by the change in ownership structure.

Next Steps

• The merger between Concentra Escrow Issuer Corporation and Concentra Health Services, Inc. is expected to close in the third quarter of 2024.
• Concentra will secure a new senior secured credit facility.
• The proceeds from the notes offering and the new credit facility will be used to pay a dividend to Select Medical and for general corporate purposes.

Key Dates

Keywords

senior notes, Concentra, Select Medical, private placement, merger, separation, escrow, dividend, financing, Rule 144A, Regulation S